MicroRNA Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global MicroRNA Market By Type (MicroRNA Arrays, Next Gen Sequencing, Immunoassay, PCR-Based Assay) By Application (Research and development, Clinical diagnostics) By End-user (Research and Academic Institutes, Biopharmaceutical Companies, Diagnostic Centers ), By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

The global microRNA market size valued USD 864.2 million in 2020 and expected to grow at a CAGR of 18.6% during the forecast period 2021-2027. A microRNA is a single-stranded RNA molecule that can be found in animals, plants and viruses. Two of the most important functions of miRNAs are post-transcriptional control of gene expression and RNA silencing. MiRNAs work in tandem with messenger RNA (mRNA) to suppress gene expression and regulate a variety of biological activities including cell differentiation, proliferation, and death. They are involved in cell physiology and development, as well as pathological processes such as viral infections, autoimmune disorders, and carcinogenesis, in addition to detecting different cell types. MiRNAs can be found in great quantities in a variety of mammalian cell types.

MicroRNA Market

MARKET SUMMARY
-
18.6% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 18.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North America

MicroRNA Market

  • The report on global microRNA market gives historical, current and future market sizes (US$ Mn) based on application, type, end user and geographical regions.
  • microRNA market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Illumina, Inc.
  • GE Healthcare
  • Agilent Technologies
MicroRNA Market

Drivers And Restraints

Growing incidence and prevalence of cancer and cardiovascular diseases is the major driving factor for growth of the MicroRNA market. As per GLOBOCON statistics, around 1, 604 cancer cases per 100,000 people were reported globally in 2012. Furthermore, increase in demand for bioinformatics, rise in usage and demand for advanced technologies, growing R&D investments by market players are expected to propel the growth of MicroRNA market. However, high cost associated with MicroRNA’s, lack of awareness, unfavourable regulatory framework is expected to dampen the Global MicroRNA market.


North-America got significant share

MicroRNA Market

Geographically Global Market is segmented as Latin America, North America, Asia Pacific, The Middle East and Africa and Europe. North America holds the largest position in global miRNA market owing to high prevalence of cancer, high adoption of advanced technology, availability of various reimbursement policies. According to American Cancer society, in U.S. one in every four deaths is accounted by cancer. Asia pacific offers lucrative opportunities due to increase in chronic diseases prevalence, growing researches on development of miRNA’s, development in healthcare sector. For example, in May 2015, an algorithm and detection technology of miRNA for non-invasive diagnosis of cancer was developed by Researchers who belongs to National University of Singapore and Agency for Science, Technology and Research (A*STAR) Bioprocessing Technology Institute.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In April 2014, Exigon launched high potent miRCURY LNA, a microRNA mimics for functional analysis.
  • In January 2014, HTG molecular Diagnostics launched an assay with nuclease protection probe technology that targets 2,275 miRNAs.

Key

Key Features of the Report

MicroRNA Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Thermo Fisher Scientific Inc.(U.S.)
  • QIAGEN (Exiqon) (Germany)
  • Illumina, Inc. (U.S.)
  • GE Healthcare (UK)
  • Agilent Technologies (U.S.)
  • GeneCopoeia, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Promega Corporation (U.S.)
  • Merck & Co., Inc.(U.S.)

Description

The global microRNA market size valued USD 864.2 million in 2020 and expected to grow at a CAGR of 18.6% during the forecast period 2021-2027. A microRNA is a single-stranded RNA molecule that can be found in animals, plants and viruses. Two of the most important functions of miRNAs are post-transcriptional control of gene expression and RNA silencing. MiRNAs work in tandem with messenger RNA (mRNA) to suppress gene expression and regulate a variety of biological activities including cell differentiation, proliferation, and death. They are involved in cell physiology and development, as well as pathological processes such as viral infections, autoimmune disorders, and carcinogenesis, in addition to detecting different cell types. MiRNAs can be found in great quantities in a variety of mammalian cell types.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX